596817-39-9 Usage
General Description
(1-Pyrmidin-4-yl-piperidin-4-yl)-carbamic acid tert-butyl ester is a chemical compound with a unique structure that consists of a pyrimidine ring fused to a piperidine ring, with a carbamic acid tert-butyl ester attached to the nitrogen atom of the piperidine ring. (1-PYRIMIDIN-4-YL-PIPERIDIN-4-YL)-CARBAMIC ACID TERT-BUTYL ESTER is commonly used in the field of medicinal chemistry and pharmaceutical research as it exhibits potential bioactivity and medicinal properties. Its unique structure makes it a valuable building block for drug discovery and development, and it is often used as a starting material for the synthesis of novel chemical entities with potential therapeutic applications. Additionally, its tert-butyl ester group provides stability and protection to the molecule, making it suitable for various synthetic and biological applications. Overall, (1-Pyrmidin-4-yl-piperidin-4-yl)-carbamic acid tert-butyl ester is a versatile and valuable chemical compound with potential applications in drug development and medicinal chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 596817-39-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,9,6,8,1 and 7 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 596817-39:
(8*5)+(7*9)+(6*6)+(5*8)+(4*1)+(3*7)+(2*3)+(1*9)=219
219 % 10 = 9
So 596817-39-9 is a valid CAS Registry Number.
596817-39-9Relevant articles and documents
FUSED MORPHLINOPYRIMIDINES AND METHODS OF USE THEREOF
-
, (2015/05/19)
The present invention relates to Fused Morpholinopyrimidines, pharmaceutical compositions comprising an effective amount of a Fused Morpholinopyrimidine and methods for using a Fused Morpholinopyrimidine in the treatment of a neurodegenerative disease, comprising administering to a subject in need thereof an effective amount of a Fused Morpholinopyrimidine.
Novel factor Xa inhibitors based on a 2-carboxyindole scaffold: SAR of P4 substituents in combination with a neutral P1 ligand
Nazare, Marc,Essrich, Melanie,Will, David W.,Matter, Hans,Ritter, Kurt,Urmann, Matthias,Bauer, Armin,Schreuder, Herman,Czech, Joerg,Lorenz, Martin,Laux, Volker,Wehner, Volkmar
, p. 4197 - 4201 (2007/10/03)
A series of novel, highly potent 2-carboxyindole-based factor Xa inhibitors is described. Structural requirements for P4 ligands in combination with a neutral biaryl P1 ligand were investigated with the 2-carboxyindole scaffold. A diverse set of P4 substituents was identified, which, in conjunction with a biaryl P1 ligand, gave highly potent factor Xa inhibitors, which were also selective versus other proteases and efficacious in various antithrombotic secondary assays.
NEW COMPOUNDS
-
Page/Page column 33, (2008/06/13)
The present invention relates to new, potent DPP-IV enzyme inhibitors of the general formula (I), which contain fluorine atoms.
